
Palborest 125mg Tablet
Marketer
MSN Laboratories
Salt Composition
Palbociclib (125mg)
Overview Palborest 125mg Tablet
Estrogen receptor-positive, HER2-negative breast cancer that has metastasized is treated with the 125mg Palborest tablet, used concomitantly with hormonal anticancer therapies. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, based on your condition and subject to change. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue use only upon your doctor's instruction. Common side effects include nausea, alopecia, skin rashes, emesis, and bowel irregularities. Palborest may induce leukopenia and thrombocytopenia, increasing infection risk. Report symptoms such as fever, chills, malaise, bleeding, or epistaxis immediately. Dizziness may occur; avoid driving or activities requiring alertness if affected. Prior to commencing treatment, disclose any existing cardiac, hepatic, or renal conditions, and all medications, including antibiotics, to your physician. Numerous drug interactions are possible; inform your healthcare provider of all concurrent medications. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is essential throughout treatment to prevent conception.
Uses of Palborest 125mg Tablet
Malignant breast tumor
Major Benefits of Palborest 125mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Palborest 125mg Tablet should be administered with a meal.
Common Side effects of Palborest 125mg Tablet:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Palborest 125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 125mg Palborest tablet whole; do not break, crush, or chew it. Administer this medicine with food.
How Palborest 125mg Tablet works:
Palborest 125mg tablets function as an anti-neoplastic agent. Its mechanism involves blocking cyclin-dependent kinases 4 and 6, key proteins driving cellular growth and division. By inhibiting these kinases, Palborest halts the progression of the cancer cell cycle. Furthermore, it specifically targets estrogen receptor-positive breast cancers, interfering with their cellular replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Palborest 125mg Tablet with alcohol is undetermined. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Using Palborest 125mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's unsafe. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the risks. Always seek medical advice.
Breast feedingUNSAFE
Lactation is contraindicated with Palborest 125mg tablets due to the potential for infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Palborest 125mg Tablets, a potential side effect being fatigue in some users. Individuals experiencing this symptom should avoid operating vehicles or machinery.
KidneySAFE IF PRESCRIBED
Palborest 125mg tablets may be administered to patients with renal impairment without the need for dosage modification.
LiverCAUTION
Patients with liver impairment should use Palborest 125mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Palborest 125mg Tablet :
NA
Facts to Know About Palborest 125mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | CDK Inhibitor |
